FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997154811> ?p ?o ?g. }

• W2997154811 endingPage "105922" @default.
• W2997154811 startingPage "105922" @default.
• W2997154811 abstract "Abstract Introduction Nonalcoholic steatohepatitis (NASH) is a sub-classification of nonalcoholic fatty liver disease (NAFLD) characterized by increased risk of progressive liver fibrosis. Cenicriviroc (CVC) is a novel, orally administered, potent chemokine 2 and 5 receptor antagonist currently in development for the treatment of liver fibrosis in adults with NASH. Methods and analysis Efficacy and safety of CVC will be comprehensively evaluated in a global, Phase 3, multicenter, randomized, double-blind, placebo-controlled study (AURORA, NCT03028740 ) of subjects with NASH and Stage F2 or F3 fibrosis. Approximately 2000 adults (Part 1, 1200 subjects; Part 2, 800 additional subjects) aged 18–75 years with histological evidence of NASH with Stage F2 or F3 fibrosis (NASH Clinical Research Network classification system) will be randomized 2:1 to CVC 150 mg or placebo orally once daily. Primary efficacy endpoints will include the proportion of subjects with ≥1-stage improvement in liver fibrosis and no worsening of steatohepatitis at Month 12 relative to screening (Part 1), and time to first occurrence of any adjudicated event: death; histopathologic progression to cirrhosis; liver transplant; Model of End-Stage Liver Disease score ≥ 15; ascites; hospitalization due to liver decompensation (Part 2). Patient-reported outcomes will assess changes in health outcomes from baseline (Chronic Liver Disease Questionnaire - NAFLD; Work Productivity and Activity Impairment in NASH; 36-Item Short Form Health Survey version 2). Adverse events will be assessed throughout the study. As there are currently no approved treatments indicated for NASH, the AURORA CVC Phase 3 study addresses an unmet medical need." @default.
• W2997154811 created "2020-01-10" @default.
• W2997154811 creator A5009427260 @default.
• W2997154811 creator A5018397988 @default.
• W2997154811 creator A5024470010 @default.
• W2997154811 creator A5038609111 @default.
• W2997154811 creator A5046528197 @default.
• W2997154811 creator A5053405300 @default.
• W2997154811 creator A5059068278 @default.
• W2997154811 creator A5066073213 @default.
• W2997154811 creator A5070639714 @default.
• W2997154811 creator A5073573770 @default.
• W2997154811 creator A5080386622 @default.
• W2997154811 creator A5083825910 @default.
• W2997154811 creator A5085052085 @default.
• W2997154811 creator A5086610543 @default.
• W2997154811 date "2020-02-01" @default.
• W2997154811 modified "2023-10-18" @default.
• W2997154811 title "Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design" @default.
• W2997154811 cites W1622799587 @default.
• W2997154811 cites W1964572117 @default.
• W2997154811 cites W1969660985 @default.
• W2997154811 cites W1981900811 @default.
• W2997154811 cites W1983417944 @default.
• W2997154811 cites W1996415443 @default.
• W2997154811 cites W1998207473 @default.
• W2997154811 cites W2033814111 @default.
• W2997154811 cites W2059613020 @default.
• W2997154811 cites W2062812115 @default.
• W2997154811 cites W2063437798 @default.
• W2997154811 cites W2067740038 @default.
• W2997154811 cites W2080166653 @default.
• W2997154811 cites W2084722601 @default.
• W2997154811 cites W2086325363 @default.
• W2997154811 cites W2087829753 @default.
• W2997154811 cites W2105359426 @default.
• W2997154811 cites W2106937897 @default.
• W2997154811 cites W2110796494 @default.
• W2997154811 cites W2118655749 @default.
• W2997154811 cites W2120056458 @default.
• W2997154811 cites W2129275826 @default.
• W2997154811 cites W2136547076 @default.
• W2997154811 cites W2141860786 @default.
• W2997154811 cites W2156792510 @default.
• W2997154811 cites W2290207881 @default.
• W2997154811 cites W2413287636 @default.
• W2997154811 cites W2467384826 @default.
• W2997154811 cites W2529917894 @default.
• W2997154811 cites W2580009538 @default.
• W2997154811 cites W2588089969 @default.
• W2997154811 cites W2734724639 @default.
• W2997154811 cites W2744982526 @default.
• W2997154811 cites W2746863374 @default.
• W2997154811 cites W2760098333 @default.
• W2997154811 cites W2781370009 @default.
• W2997154811 cites W2789841804 @default.
• W2997154811 cites W2791821840 @default.
• W2997154811 cites W2792789024 @default.
• W2997154811 cites W2794639926 @default.
• W2997154811 cites W2804761314 @default.
• W2997154811 cites W2805977157 @default.
• W2997154811 cites W2806839461 @default.
• W2997154811 cites W2810236669 @default.
• W2997154811 cites W2821544409 @default.
• W2997154811 cites W2891522467 @default.
• W2997154811 cites W2955603751 @default.
• W2997154811 cites W4292806894 @default.
• W2997154811 doi "https://doi.org/10.1016/j.cct.2019.105922" @default.
• W2997154811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31881392" @default.
• W2997154811 hasPublicationYear "2020" @default.
• W2997154811 type Work @default.
• W2997154811 sameAs 2997154811 @default.
• W2997154811 citedByCount "81" @default.
• W2997154811 countsByYear W29971548112020 @default.
• W2997154811 countsByYear W29971548112021 @default.
• W2997154811 countsByYear W29971548112022 @default.
• W2997154811 countsByYear W29971548112023 @default.
• W2997154811 crossrefType "journal-article" @default.
• W2997154811 hasAuthorship W2997154811A5009427260 @default.
• W2997154811 hasAuthorship W2997154811A5018397988 @default.
• W2997154811 hasAuthorship W2997154811A5024470010 @default.
• W2997154811 hasAuthorship W2997154811A5038609111 @default.
• W2997154811 hasAuthorship W2997154811A5046528197 @default.
• W2997154811 hasAuthorship W2997154811A5053405300 @default.
• W2997154811 hasAuthorship W2997154811A5059068278 @default.
• W2997154811 hasAuthorship W2997154811A5066073213 @default.
• W2997154811 hasAuthorship W2997154811A5070639714 @default.
• W2997154811 hasAuthorship W2997154811A5073573770 @default.
• W2997154811 hasAuthorship W2997154811A5080386622 @default.
• W2997154811 hasAuthorship W2997154811A5083825910 @default.
• W2997154811 hasAuthorship W2997154811A5085052085 @default.
• W2997154811 hasAuthorship W2997154811A5086610543 @default.
• W2997154811 hasBestOaLocation W29971548111 @default.
• W2997154811 hasConcept C126322002 @default.
• W2997154811 hasConcept C2776954865 @default.
• W2997154811 hasConcept C2778772119 @default.
• W2997154811 hasConcept C2779134260 @default.
• W2997154811 hasConcept C2779478299 @default.

• next